and answers2026 update
Question1 1
out h,of h,1 h,points
When an unstable patient asks why it is necessary to add
h, h, h, h, h, h, h, h, h, h,
medications to his current regimen, the PMHNP’s best
h, h, h, h, h, h, h, h,
response would be:
h, h, h,
Selected h,C.
Answer: h , “Many h,psychiatric h,illnesses h,involve h,several h,dys-functioning h,neurotransmitter
h,systems h,in h,the h,brain. h,Often, h,a h,single h,medication h,may h,only h,effect h,one h,or h,two h,of
h,the h,dys-functioning h,systems. h,The h,addition h,of h,another h,medication h,can h,work h,with
h,the h,current h,medication h,in h,stabilizing h,multiple h,neurotransmitter h,systems h,and h,help
h,to h,alleviate h,your h,symptoms.”
• Question 2 h,
0 h,out h,of h,1
h, points h,The h,PMHNP h,is h, meeting h, with h,a h,new h, mother h, who h, would h,like h,to
begin taking medication again to treat her bipolar depression; she
h, h, h, h, h, h, h, h, h, h,
is breastfeeding her 2-month old daughter. The PMHNP recognizes
h, h, h, h, h, h, h, h, h,
that which of the following medications is contraindicated for this
h, h, h, h, h, h, h, h, h,
patient?
h,
Selected C.
h,Answer: Lithium
(Lithobid)
h,
• Question 3 h,
1 h,out h, of h,1 h,points
Mr. Gordon is a middle-aged client who was started on antidepressant
h, h, h, h, h, h, h, h, h, h,
monotherapy for depression. After beginning this medication, the
h, h, h, h, h, h, h, h,
PMHNP noticed that this client seemed to swing into a hypomanic
h, h, h, h, h, h, h, h, h, h, h,
episode. What can the PMHNP infer from this behavior change?
h, h, h, h, h, h, h, h, h, h,
Selected A.
h,Answer: This client may have Bipolar III disorder
h, h, h, h, h, h,
• Question 4 h,
1 h,out h,of h,1 h,points
A patient presents with frequent episodes of mania. Which
h, h, h, h, h, h, h, h,
statement describes an appropriate treatment approach for this
h, h, h, h, h, h, h, h,
patient?
h,
Selected B.
h,Answer: “The patient could benefit from an
h, h, h, h, h,
, anticonvulsant.”
• Question 5 h,
1 h,out h,of h,1 h,points
The student inquires about antipsychotic medications. Which
h, h, h, h, h, h,
response by the PMHNP describes the factors that contribute to
h, h, h, h, h, h, h, h, h, h,
reduced risk of extrapyramidal symptoms (EPS) for patients who
h, h, h, h, h, h, h, h, h,
take antipsychotics?
h, h,
Selected B.
h,Answer Those that are potent D2 antagonists with 5HT2A
h, h, h, h, h, h, h,
: antagonism properties
h, h,
• Question 6 h,
1 h,out h,of h,1 h,points
After h,ordering h,flumazenil h,(Rumazicon) h,the h,PMHNP h,cautions h,the h,staff h,to h,monitor h,for
h,which h,possible h,effect?
Selected D.
h,Answer: All h,ofh,the
h, above
• Question 7 h,
1 h,out h,of h,1 h,points
The PMHNP is caring for a patient who is taking antipsychotics
h, h, h, h, h, h, h, h, h, h,
heard the psychiatrist tell the patient that the patient would be
h, h, h, h, h, h, h, h, h, h, h,
placed on a different antipsychotic agent called an atypical
h, h, h, h, h, h, h, h, h,
antipsychotic. What neurotransmitters will this new medication work on?
h, h, h, h, h, h, h, h, h,
Selected A.
h,Answer: dopamine and serotonin h, h,
• Question 8 h,
1 h,out h,of h,1 h,points
While genes have potential to modify behavior, behavior can
h, h, h, h, h, h, h, h,
also modify genes. How do genes impact this process?
h, h, h, h, h, h, h, h, h,
Selected B.
h,Answer: Changes made to proteins lead to changes h, h, h, h, h, h,
in behavior.
h, h,
• Question 9 h,
1 h,out h,of h,1 h,points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and no
h, h, h, h, h, h, h, h, h,
established history of depression. When meeting with the PMHNP, she
h, h, h, h, h, h, h, h, h, h,
presents with apathy and withdrawn social behavior, and she reports a
h, h, h, h, h, h, h, h, h, h, h,
loss of joy from enjoyable activities since starting her new medication.
h, h, h, h, h, h, h, h, h, h, h,
What does
h, h,
, the PMHNP infer from this encounter with the client?
h, h, h, h, h, h, h, h,
Selected C.
h,Answer: The h,new h,medication h,is h,blocking h,D2 h,receptors h,in h,the h,mesolimbic
h,system
• Question 10 h,
1 h,out h,of h,1 h,points
A nursing student is seeking clarification on the use
h, h, h, h, h, h, h, h,
of
h,
anticonvulsants to treat depression and is unclear about h, h, h, h, h, h, h,
h,most effective outcomes. Which of the following agents does
h, h, h, h, h, h, h, h,
the PMHNP convey as having uncertain outcomes?
h, h, h, h, h, h, h,
Selected B.
h,Answer: Gabapentin
(Neurontin)
h,
• Question 11 h,
1 h,out h,of h,1 h,points
As it relates to G-protein linked receptors, what does the
h, h, h, h, h, h, h, h, h,
PMHNP understand about medications that are used in
h, h, h, h, h, h, h, h,
practice?
h,
Selected A.
h,Answer Most medications that act on G-protein linked
h, h, h, h, h, h,
: receptors have antagonistic traits.
h, h, h, h,
• Question 12 h,
1 h,out h,of h,1 h,points
A patient is seeking pharmacological treatment for smoking
h, h, h, h, h, h, h,
cessation. Which drug class does the PMHNP prescribe to the
h, h, h, h, h, h, h, h, h, h,
patient?
h,
Selected D.
h,Answer: Varenicline
(Chantix)
h,
• Question 13 h,
1 h,out h,of h,1 h,points
The PMHNP is caring for a patient with schizophrenia and is
h, h, h, h, h, h, h, h, h, h,
considering a variety of treatment approaches. The PHMNP
h, h, h, h, h, h, h, h,
selects a viable treatment that is consistent with the
h, h, h, h, h, h, h, h, h,
“dopamine hypothesis of schizophrenia.” What action does the
h, h, h, h, h, h, h, h,
PMHNP anticipate this treatment having on the patient?
h, h, h, h, h, h, h, h,
Selected B.
Answer: